JPMorgan Chase & Co’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $138K | Sell |
32,479
-254,454
| -89% | -$1.08M | ﹤0.01% | 4648 |
|
|
2025
Q1 | $1.08M | Buy |
286,933
+126,182
| +78% | +$474K | ﹤0.01% | 3613 |
|
|
2024
Q4 | $937K | Sell |
160,751
-20,281
| -11% | -$118K | ﹤0.01% | 3839 |
|
|
2024
Q3 | $2.16M | Buy |
181,032
+157,171
| +659% | +$1.88M | ﹤0.01% | 3216 |
|
|
2024
Q2 | $258K | Buy |
23,861
+976
| +4% | +$10.6K | ﹤0.01% | 4146 |
|
|
2024
Q1 | $259K | Sell |
22,885
-5,691
| -20% | -$64.4K | ﹤0.01% | 4320 |
|
|
2023
Q4 | $401K | Buy |
28,576
+10,203
| +56% | +$143K | ﹤0.01% | 4030 |
|
|
2023
Q3 | $227K | Sell |
18,373
-2,596
| -12% | -$32.1K | ﹤0.01% | 4169 |
|
|
2023
Q2 | $189K | Buy |
20,969
+19,775
| +1,656% | +$179K | ﹤0.01% | 4301 |
|
|
2023
Q1 | $4K | Hold |
1,194
| – | – | ﹤0.01% | 5435 |
|
|
2022
Q4 | $3K | Sell |
1,194
-281,081
| -100% | -$706K | ﹤0.01% | 5310 |
|
|
2022
Q3 | $779K | Buy |
282,275
+1,294
| +0.5% | +$3.57K | ﹤0.01% | 3512 |
|
|
2022
Q2 | $1.14M | Buy |
280,981
+252,181
| +876% | +$1.03M | ﹤0.01% | 3374 |
|
|
2022
Q1 | $122K | Buy |
28,800
+4,928
| +21% | +$20.9K | ﹤0.01% | 4655 |
|
|
2021
Q4 | $224K | Buy |
23,872
+6,354
| +36% | +$59.6K | ﹤0.01% | 4479 |
|
|
2021
Q3 | $483K | Sell |
17,518
-89,682
| -84% | -$2.47M | ﹤0.01% | 3986 |
|
|
2021
Q2 | $3M | Buy |
107,200
+6,890
| +7% | +$193K | ﹤0.01% | 2979 |
|
|
2021
Q1 | $3.33M | Buy |
100,310
+26,807
| +36% | +$890K | ﹤0.01% | 2919 |
|
|
2020
Q4 | $3.53M | Buy |
+73,503
| New | +$3.53M | ﹤0.01% | 2634 |
|